Nkarta (NKTX) Operating Expenses (2019 - 2026)
Nkarta's quarterly Operating Expenses came in at $30.9 million in Q1 2026, down 15.56% year-on-year from $36.6 million in Q1 2025, and little changed quarter-over-quarter from $31.0 million in Q4 2025.
Nkarta has reported Operating Expenses for 8 years, with the latest figure at $30.9 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses fell 15.56% year-over-year to $30.9 million; the trailing twelve-month figure through Mar 2026 stood at $116.3 million (down 11.88% YoY), and the FY2025 full-year result was $122.0 million, down 4.83% from the prior year.
- Operating Expenses for Q1 2026 stood at $30.9 million, roughly flat from $31.0 million in the prior quarter.
- The five-year high for Operating Expenses was $36.9 million in Q2 2023, with the low at $26.1 million in Q1 2022.
- Average Operating Expenses over 5 years is $31.3 million, with a median of $30.9 million recorded in 2024.
- Year-over-year, Operating Expenses surged 52.85% in 2022 and retreated 19.26% in 2025.
- Tracing NKTX's Operating Expenses over 5 years: stood at $35.0 million in 2022, then decreased by 10.86% to $31.2 million in 2023, then dropped by 0.84% to $30.9 million in 2024, then grew by 0.12% to $31.0 million in 2025, then fell by 0.27% to $30.9 million in 2026.
- The last three Operating Expenses figures came in at $30.9 million (Q1 2026), $31.0 million (Q4 2025), and $27.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.33 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -138.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.85 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.96 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 898.54 Mn |
| 10 | Nkarta | 232.80 Mn | 232.80 Mn | - | 30.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.88 Mn |
| Dec 31, 2025 | 30.96 Mn |
| Sep 30, 2025 | 27.29 Mn |
| Jun 30, 2025 | 27.19 Mn |
| Mar 31, 2025 | 36.56 Mn |
| Dec 31, 2024 | 30.92 Mn |
| Sep 30, 2024 | 33.79 Mn |
| Jun 30, 2024 | 30.72 Mn |
| Mar 31, 2024 | 32.76 Mn |
| Dec 31, 2023 | 31.19 Mn |
| Sep 30, 2023 | 29.29 Mn |
| Jun 30, 2023 | 36.86 Mn |
| Mar 31, 2023 | 34.31 Mn |
| Dec 31, 2022 | 34.98 Mn |
| Sep 30, 2022 | 30.26 Mn |
| Jun 30, 2022 | 27.61 Mn |
| Mar 31, 2022 | 26.10 Mn |
| Dec 31, 2021 | 22.89 Mn |
| Sep 30, 2021 | 22.43 Mn |
| Jun 30, 2021 | 21.63 Mn |
| Mar 31, 2021 | 19.48 Mn |
| Dec 31, 2020 | 18.00 Mn |
| Sep 30, 2020 | 13.75 Mn |
| Jun 30, 2020 | 10.36 Mn |
| Mar 31, 2020 | 9.41 Mn |
| Dec 31, 2019 | 8.65 Mn |
| Sep 30, 2019 | 5.91 Mn |
| Jun 30, 2019 | 4.67 Mn |